Please find enclosed herewith the newspaper advertisement for the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30th June 2025, published in Financial Express ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sudarshan Pharma Industries has filed copies of newspaper advertisements of its unaudited standalone and consolidated financial results for the quarter ended 30th June 2025 with BSE. The results were published in Mumbai Lakshdeep and Financial Express newspapers. The intimation was signed by Nirav Shah, Company Secretary, and dated 18th August 2025. The filing is a routine SEBI compliance requirement under Regulation 33 of the Listing Regulations, mandating companies to publish quarterly results in at least one English and one regional language newspaper. No new financial figures are disclosed in this filing beyond what was already shared in the original results announcement.
This is a standard regulatory compliance filing with no fresh information for shareholders. The actual Q1 FY26 numbers were disclosed earlier in the results filing; this is just evidence of the mandatory newspaper publication. No material impact on the stock is expected from this specific filing.